生血宝合剂辅助治疗对血液肿瘤患者化疗后毒副反应及免疫功能的影响
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R733

基金项目:


Effect of Shengxuebao Mixture as Adjuvant Treatment on Toxic Side Effects and Immune Function of Patients with Hematological Tumor After Chemotherapy
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察生血宝合剂辅助治疗对血液肿瘤患者化疗后毒副反应及免疫功能的影响。方法:将96 例血液肿瘤患者按随机数字表法分为对照组和观察组各48 例。对照组给予常规化疗进行治疗,观察组在对照组的基础上联合生血宝合剂治疗。2 组均完成3 个疗程的化疗,观察比较2 组治疗前后血液指标(白细胞、血红蛋白、血小板) 水平,免疫学指标(CD3+、CD4+、CD4+/CD8+)、血液系统毒副反应程度分级及常见不良反应发生情况。结果:治疗前,2 组白细胞计数、血红蛋白、血小板计数、CD3+、CD4+、CD4+/CD8+水平比较,差异无统计学意义(P>0.05);治疗后,2 组白细胞计数、血红蛋白、血小板计数、CD3+、CD4+、CD4+/CD8+均较治疗前降低(P<0.05),但观察组上述6 项指标均高于对照组(P<0.05)。治疗后,观察组白细胞、血红蛋白、血小板毒副反应分级情况均优于对照组,骨髓抑制、消化道反应、皮肤反应、局部刺激、肝肾功能异常发生率均低于对照组,差异均有统计学意义(P<0.05)。结论:生血宝合剂辅助治疗能够改善血液肿瘤患者化疗的毒副反应,保护血液系统,改善免疫功能损害,不良反应相对较少。

    Abstract:

    Abstract: Objective: To observe the effect of Shengxuebao mixture as adjuvant treatment on toxic side effects and immune function of patients with hematological tumor after chemotherapy. Methods: A total of 96 cases of patients with hematological tumor were divided into the control group and the observation group according to the random number table method, 48 cases in each group. The control group was given routine chemotherapy, and the observation group was additionally given Shengxuebao mixture based on the treatment of the control group. The chemotherapy lasted for three courses in both groups. Before and after treatment, levels of blood indexes(leukocytes, hemoglobin, platelets) and immunological indexes(CD3 +,CD4 +,CD4 +/CD8 + ),the classification of toxic side effects on blood system,as well as the incidence of common adverse reactions were observed and compared between the two groups. Results:Before treatment, when compared levels of leukocytes, hemoglobin, platelets, CD3 + , CD4 + , and CD4 +/CD8 + between the two groups , there was no significance in the difference(P>0.05). After treatment,levels of leukocytes,hemoglobin,platelets,CD3+, CD4+,and CD4+/CD8+ in the two groups were decreased when compared with those before treatment(P<0.05),but the six levels above in the observation group were higher than those in the control group(P<0.05). After treatment,the classification of toxic side effects on leukocytes,hemoglobin,and platelets in the observation group was better than that in the control group,and the abnormal incidence of myelosuppression,gastrointestinal tract reaction,skin response,local stimulation, the liver function and the kidney function was lower than that in the control group, differences being significant(P<0.05). Conclusion:Shengxuebao mixture in adjuvant therapy of patients with hematological tumor can relieve toxic side effects of chemotherapy,protect blood system,and improve injury of immune function,with fewer adverse reactions.

    参考文献
    相似文献
    引证文献
引用本文

王璇.生血宝合剂辅助治疗对血液肿瘤患者化疗后毒副反应及免疫功能的影响[J].新中医,2021,53(12):136-139

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2021-06-23
  • 出版日期:
文章二维码